A Case of Advanced Hepatocellular Carcinoma with Multiple Intrahepatic Metastases and Peritoneal Dissemination Treated using Atezolizumab plus Bevacizumab Combination Therapy, Resulted in Pathological Complete Response, with Concomitant Endoscopic Therapies for Early Gastric and Colorectal Cancers-Reference-Cited by-同舟云学术

A Case of Advanced Hepatocellular Carcinoma with Multiple Intrahepatic Metastases and Peritoneal Dissemination Treated using Atezolizumab plus Bevacizumab Combination Therapy, Resulted in Pathological Complete Response, with Concomitant Endoscopic Therapies for Early Gastric and Colorectal Cancers

Published:2024-09-01 Issue:9 Volume:65 Page:440-448
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Kanzo

Author:

Ka Itsumi¹,Nakata Akinori¹,Ishii Shotaro¹,Yamamoto Yuya¹,Matsuda Dan¹,Sasaki Hirotaka¹,Shimoda Miki¹,Sakisaka Kensuke¹,Matsuyama Taichi¹,Mizumoto Takao²,Yanagida Eriko³,Sugi Kazuhiro¹

Affiliation:

1. Department of Gastroenterology and Hepatology, National Hospital Organization Kumamoto Medical Center

2. Department of Surgery, National Hospital Organization Kumamoto Medical Center

3. Department of Diagnostic Pathology, National Hospital Organization Kumamoto Medical Center

Publisher

Japan Society of Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/65/9/65_440/_pdf

Reference18 articles.

1. 1) J Bruix, M Sherman, JM Llovet, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35 (3): 421-430

2. 2) Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359 (4): 378-390

3. 3) Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10 (1): 25-34

4. 4) Merle P. The New immuno-oncology-based therapies and their perspectives in hepatocellular carcinoma. Cancers 2021; 13 (2): 238

5. 5) Alison L Raybould, Hanna Sanoff, et al. Combination antiangiogenic and immunotherapy for advanced hepatocellular carcinoma: Evidence to date. J Hepatocell Carcinoma 2020; 15 (7): 133-142